These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10725437)

  • 1. DNA-containing and empty hepatitis B virus core particles bind similarly to envelope protein domains.
    Hourioux C; Touzé A; Coursaget P; Roingeard P
    J Gen Virol; 2000 Apr; 81(Pt 4):1099-101. PubMed ID: 10725437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
    Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation.
    Cui X; Luckenbaugh L; Bruss V; Hu J
    J Virol; 2015 Oct; 89(19):10064-72. PubMed ID: 26202253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsid Phosphorylation State and Hepadnavirus Virion Secretion.
    Ning X; Basagoudanavar SH; Liu K; Luckenbaugh L; Wei D; Wang C; Wei B; Zhao Y; Yan T; Delaney W; Hu J
    J Virol; 2017 May; 91(9):. PubMed ID: 28228589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Hepatitis B Virus Virion Release and Envelopment Timing by Nucleocapsid and Envelope Interactions.
    Xi J; Liu H; Hu J
    J Virol; 2022 Jan; 96(1):e0130521. PubMed ID: 34643434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.
    Hu J; Liu K
    Viruses; 2017 Mar; 9(3):. PubMed ID: 28335554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
    Orabi A; Bieringer M; Geerlof A; Bruss V
    J Virol; 2015 Sep; 89(18):9281-7. PubMed ID: 26136564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis.
    Gerelsaikhan T; Tavis JE; Bruss V
    J Virol; 1996 Jul; 70(7):4269-74. PubMed ID: 8676448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation.
    Yang L; Wang YJ; Chen HJ; Shi LP; Tong XK; Zhang YM; Wang GF; Wang WL; Feng CL; He PL; Xu YB; Lu MJ; Tang W; Nan FJ; Zuo JP
    Antiviral Res; 2016 Jan; 125():25-33. PubMed ID: 26611395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions.
    Seitz S; Urban S; Antoni C; Böttcher B
    EMBO J; 2007 Sep; 26(18):4160-7. PubMed ID: 17762862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.
    Poisson F; Severac A; Hourioux C; Goudeau A; Roingeard P
    Virology; 1997 Feb; 228(1):115-20. PubMed ID: 9024817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelopment of the hepatitis B virus nucleocapsid.
    Bruss V
    Virus Res; 2004 Dec; 106(2):199-209. PubMed ID: 15567498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
    Sureau C; Salisse J
    Hepatology; 2013 Mar; 57(3):985-94. PubMed ID: 23161433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
    Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
    N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HBV envelope and nucleocapsid proteins in human cells using vaccinia virus vectors.
    Mondelli M; Baldick J; McLachlan A; Chisari FV; Moss B
    Ital J Gastroenterol; 1990 Jun; 22(3):115-7. PubMed ID: 1966705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation.
    Ponsel D; Bruss V
    J Virol; 2003 Jan; 77(1):416-22. PubMed ID: 12477846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
    Ren S; Nassal M
    J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.